Rebecca A. Alderden, Matthew D. Hall, and Trevor W. Hambley
Centre for Heavy Metals Research, School of Chemistry, The University of Sydney, 2006 NSW, Australia
Cisplatin is currently one of the most widely used anticancer drugs in the world. The unlikely events surrounding the discovery of its anticancer activity, subsequent introduction into the clinic, and the continuing research into platinum compounds is the subject of this review. Cisplatin and related platinum compounds remain the focus of extensive research. Reliable methods for the synthesis of such compounds have been developed and it has been established that they exert their anticancer activity through interaction with DNA. The search continues for a platinum drug to improve upon the clinical performance of cisplatin. Several have entered clinical trials but have been abandoned for a variety of reasons. However, preliminary results on novel compounds have been particularly promising.
More Information
Citation
Alderden, Rebecca A.; Hall, Matthew D.; Hambley, Trevor W. J. Chem. Educ.2006 83 728.
Our Secondary School editors work hard to distill all the JCE materials to produce a fraction of particular interest to high school teachers. We call it CLIC.
In recent years we have worked hard to better match our advertisers with our readers. When shopping for chemistry education materials, visit our advertisers' WWW sites first.
Take JCE along on your outreach missions. Copies of the Journal, guest access to JCE Online, our publications catalog, and more are available for your participants.